Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Immunocellular Therapeutics: An Interesting Biotech
Seeking Alpha
Tuesday, July 19, 2011 - 12:12pm
tags:
ImmunoCellular Therapeutics, cancer, Bristol-Myers Squibb, Dendreon, Oncothyreon
Medicis shares tumble again
Bizjournals.com
Tuesday, July 19, 2011 - 12:11pm
tags:
Medicis, Jonah Shacknai
Allergan to buy Vicept, developer of experimental rosacea treatment
Bizjournals.com
Tuesday, July 19, 2011 - 12:09pm
tags:
Allergan, Vicept, Rosacea, M&A
J&J Slips After Earnings Despite Beat; Is Guidance Conservative?
Barron's
Tuesday, July 19, 2011 - 11:55am
tags:
earnings, guidance, JNJ
Dawn of A New Sleep Drug?
WSJ Online
Tuesday, July 19, 2011 - 11:54am
tags:
insomnia, GSK, Actelion, Sanofi
Pozen brings in digital advisers
Bizjournals.com
Tuesday, July 19, 2011 - 11:19am
tags:
Pozen, digital pharma
Lilly Says Alzheimer Patients Didn’t Improve
Bloomberg
Tuesday, July 19, 2011 - 11:00am
tags:
Alzheimer's disease, semagacestat
J&J’s Profit Beats Analysts’ Estimates on Prostate Cancer, Psoriasis Drugs
Bloomberg
Tuesday, July 19, 2011 - 10:23am
tags:
earnings, JNJ
Earnings Preview: Eli Lilly reports on 2Q Thursday
Yahoo/AP
Tuesday, July 19, 2011 - 10:22am
tags:
earnings, Eli Lilly
Novartis Says Priority Is to Pay Down Debt; to Seek Acquisitions
Bloomberg
Tuesday, July 19, 2011 - 10:22am
tags:
Novartis, M&A, debt, Joe Jimenez, Pharma CEOs
Novartis net profit rises 12% on sales gain of 27%
Marketwatch
Tuesday, July 19, 2011 - 10:16am
tags:
Novartis, earnings
Johnson & Johnson board report recommends new oversight panel, shareholder suit dismissal
Yahoo/AP
Tuesday, July 19, 2011 - 10:16am
tags:
JNJ, shareholders, Omnicare
Eli Lilly: Poised to Reward Patient Investors?
Seeking Alpha
Tuesday, July 19, 2011 - 10:15am
tags:
Eli Lilly, investors, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Forest Labs, Impax, Mylan, Teva Pharmaceuticals, Watson Pharmaceuticals
GSK pledges $10M to education
Bizjournals.com
Tuesday, July 19, 2011 - 10:13am
tags:
GSK, Education, donations
Amgen's Xgeva Wins EU Approval
Yahoo/Zacks.com
Tuesday, July 19, 2011 - 10:13am
tags:
Amgen, Xgeva, Europe, GSK, denosumab, Novartis
Vical's Uptrend Shows a Strong Heartbeat
Seeking Alpha
Monday, July 18, 2011 - 5:37pm
tags:
Vical, TransVax, CMV
Alkermes Sees 2012 Revenue Up to $480 Million on Elan Deal
Bloomberg
Monday, July 18, 2011 - 5:35pm
tags:
Elan, Alkermes, earnings
The Tale of 2 Drug Handbacks
Motley Fool
Monday, July 18, 2011 - 5:33pm
tags:
Exelixis, Bristol-Myers Squibb, cabozantinib, XL-281
MedImmune begins shipping influenza vaccine
Yahoo/AP
Monday, July 18, 2011 - 1:45pm
tags:
vaccines, Flu, MedImmune
Lupin Said to Consider Sale of Indian Drugs Unit; Deal May Reap $1 Billion
Bloomberg
Monday, July 18, 2011 - 12:57pm
tags:
Lupin, India, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.